{
    "organizations": [],
    "uuid": "1d308d712d0c2f2cfceee879f9645101742d2e81",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-emblem-and-canntab-receive-health/brief-emblem-and-canntab-receive-health-canada-approval-for-rd-of-cannabinoid-based-oral-sustained-release-formulation-idUSFWN1SL0NQ",
    "ord_in_thread": 0,
    "title": "BRIEF-Emblem And Canntab Receive Health Canada Approval For R&D Of Cannabinoid-Based Oral Sustained Release Formulation",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 14 (Reuters) - Emblem Corp:\n* EMBLEM AND CANNTAB THERAPEUTICS ANNOUNCE HEALTH CANADA APPROVAL FOR RESEARCH AND DEVELOPMENT OF CANNABINOID-BASED ORAL SUSTAINED RELEASE FORMULATION Source text for Eikon: Further company coverage:\nOur Standards: The Thomson Reuters Trust Principles. 0 : 0 narrow-browser-and-phone medium-browser-and-portrait-tablet landscape-tablet medium-wide-browser wide-browser-and-larger medium-browser-and-landscape-tablet medium-wide-browser-and-larger above-phone portrait-tablet-and-above above-portrait-tablet landscape-tablet-and-above landscape-tablet-and-medium-wide-browser portrait-tablet-and-below landscape-tablet-and-below Apps Newsletters Reuters Plus Advertising Guidelines Cookies Terms of Use Privacy\nAll Quote: s delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.\nÂ© 2018 Reuters. All Rights Reserved.",
    "published": "2018-05-14T20:07:00.000+03:00",
    "crawled": "2018-05-15T14:08:40.013+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "emblem",
        "corp",
        "emblem",
        "canntab",
        "therapeutic",
        "announce",
        "health",
        "canada",
        "approval",
        "research",
        "development",
        "oral",
        "sustained",
        "release",
        "formulation",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle",
        "apps",
        "newsletter",
        "reuters",
        "plus",
        "advertising",
        "guideline",
        "cooky",
        "term",
        "use",
        "privacy",
        "quote",
        "delayed",
        "minimum",
        "minute",
        "see",
        "complete",
        "list",
        "exchange",
        "delay",
        "reuters",
        "right",
        "reserved"
    ]
}